Plain-English translation of NCT06977230 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether remote ischemic preconditioning can protect your heart during coronary artery bypass graft surgery. Remote ischemic preconditioning is a simple procedure where a blood pressure cuff on your arm is inflated and deflated several times before surgery. Researchers believe this treatment may reduce heart damage that can occur during bypass surgery, especially in people with diabetes.
Heart damage during bypass surgery is a common concern, particularly for patients with diabetes who are at higher risk. This treatment may offer a low-cost, non-invasive way to strengthen the heart's ability to tolerate the stress of surgery.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to either receive the arm cuff treatment before your bypass surgery or to receive standard care without the treatment. The cuff treatment involves five cycles of inflating a blood pressure cuff on your upper arm for 5 minutes, then deflating it for 5 minutes, done right before your surgery begins. After surgery, researchers will measure a heart enzyme in your blood at 24, 48, and 72 hours to see if the treatment protected your heart. Your hospital stay and recovery will be tracked as part of the study.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Turkey (Türkiye)